HK Stock Market Move | Brain-computer interface catalysis again, NANJING PANDA (00553) up nearly 5%, MICROPORT NEURO (02172) up nearly 4%
Brain-computer concept stocks rose, as of the time of writing, Nanjing Panda Electronics Co., Ltd. (00553) rose by 4.93% to 5.11 Hong Kong dollars; NeuroBIO Limited (02172) rose by 3.72% to 14.22 Hong Kong dollars.
Concept stocks related to brain-machine interface are on the rise. As of the time of writing, NANJING PANDA (00553) has risen by 4.93% to HK$5.11, while MICROPORT NEURO (02172) has risen by 3.72% to HK$14.22.
On the news front, it has been reported that Apple is collaborating with a brain-machine interface company to develop technology standards for "controlling Apple devices using brain signals." A demonstration video released on Monday showcased the progress of this technology for the first time. The video showed a patient with ALS successfully controlling an iPad with their thoughts using a brain-machine device, demonstrating the use of "quick commands" and other operations through brain-machine interface.
According to CCTV News, in order to support innovation in pharmaceuticals and medical devices, the National Medical Insurance Bureau has established a new pricing mechanism for newly launched drugs, adding over 100 pricing items related to new medical technologies. Among them, guidelines for neurology have set standard prices for items such as "brain-machine interface implantation fees" and "brain-machine interface adaptation fees." Once brain-machine interface technology is mature and approved for clinical use, it can quickly enter clinical applications and be charged for. Xiangcai Securities believes that as a cutting-edge technology in the medical field, the application of brain-machine interface will gradually be implemented in areas such as patient monitoring, disease rehabilitation, and skill substitution.
Related Articles

BP p.l.c. Sponsored ADR (BP.US) exceeded earnings expectations in Q2. The new chairman will lead reforms and launch a comprehensive review of the business.

HK Stock Market Move | JUNSHI BIO (01877) rose nearly 35% in the final trading session. The company had previously raised over 1 billion for research and development of PD-1/VEGF bispecific antibodies, among other projects.

Liquor giant Diageo plc Sponsored ADR (DEO.US) exceeded expectations for the 2025 fiscal year performance. It is expected that organic sales will grow by 1.7% in the 2026 fiscal year, and further cost reductions are planned.
BP p.l.c. Sponsored ADR (BP.US) exceeded earnings expectations in Q2. The new chairman will lead reforms and launch a comprehensive review of the business.

HK Stock Market Move | JUNSHI BIO (01877) rose nearly 35% in the final trading session. The company had previously raised over 1 billion for research and development of PD-1/VEGF bispecific antibodies, among other projects.

Liquor giant Diageo plc Sponsored ADR (DEO.US) exceeded expectations for the 2025 fiscal year performance. It is expected that organic sales will grow by 1.7% in the 2026 fiscal year, and further cost reductions are planned.

RECOMMEND

EU Defers Two Retaliatory Measures Against U.S. Tariffs by Six Months to Facilitate Trade Negotiations
05/08/2025

July Special Bond Issuance Reaches Year-to-Date Peak, Poised to Reinforce Infrastructure Investment
05/08/2025

Inbound Tourism Accelerates as China’s Travel Service Exports Jump Nearly 70% in H1
05/08/2025